Connecticut 2011 Regular Session

Connecticut Senate Bill SB01084 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1		General Assembly Raised Bill No. 1084
2	2		January Session, 2011 LCO No. 3589
3		-	_____~~SB01084INS~~__~~_031611____~~
	3	+	03589_______INS
4	4		Referred to Committee on Insurance and Real Estate
5	5		Introduced by:
6	6		(INS)
7	7
8	8		General Assembly
9	9
10	10		Raised Bill No. 1084
11	11
12	12		January Session, 2011
13	13
14	14		LCO No. 3589
15	15
16		-	_____~~SB01084INS~~__~~_031611____~~
	16	+	03589_______INS
17	17
18	18		Referred to Committee on Insurance and Real Estate
19	19
20	20		Introduced by:
21	21
22	22		(INS)
23	23
24	24		AN ACT CONCERNING OUT-OF-POCKET EXPENSES FOR NONPREFERRED BRAND NAME DRUGS.
25	25
26	26		Be it enacted by the Senate and House of Representatives in General Assembly convened:
27	27
28	28		Section 1. (NEW) (Effective January 1, 2012) No insurer, fraternal benefit society, hospital service corporation, medical service corporation, health care center or other entity that delivers, issues for delivery, renews, amends or continues in this state an individual health insurance policy that provides coverage for prescription drugs shall impose a coinsurance, copayment, deductible or other out-of-pocket expense for nonpreferred brand name drugs that places a greater financial burden on an insured than for preferred brand name drugs.
29	29
30	30		Sec. 2. (NEW) (Effective January 1, 2012) No insurer, fraternal benefit society, hospital service corporation, medical service corporation, health care center or other entity that delivers, issues for delivery, renews, amends or continues in this state a group health insurance policy that provides coverage for prescription drugs shall impose a coinsurance, copayment, deductible or other out-of-pocket expense for nonpreferred brand name drugs that places a greater financial burden on an insured than for preferred brand name drugs.
31	31
32	32
33	33
34	34
35	35		This act shall take effect as follows and shall amend the following sections:
36	36		Section 1 January 1, 2012 New section
37	37		Sec. 2 January 1, 2012 New section
38	38
39	39		This act shall take effect as follows and shall amend the following sections:
40	40
41	41		Section 1
42	42
43	43		January 1, 2012
44	44
45	45		New section
46	46
47	47		Sec. 2
48	48
49	49		January 1, 2012
50	50
51	51		New section
52	52
	53	+	Statement of Purpose:
53	54
	55	+	To prohibit insurers from imposing a greater coinsurance, copayment, deductible or other out-of-pocket expense for nonpreferred brand name drugs than for preferred brand name drugs.
54	56
55		-	INS Joint Favorable
56		-
57		-	INS
58		-
59		-	Joint Favorable
	57	+	[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]